Zydus Cadila
Zydus Cadila gets USFDA nod for cancer, high blood pressure treatment drug
Zydus seeks DCGI nod for add'l indication of Hep C drug in Covid-19 therapy
Zydus Cadila seeks approval for its repurpose Hepatitis C drug for Covid-19
Zydus Cadila receives tentative nod from USFDA to market two HIV drugs
Zydus Cadila reduces price of generic Covid-19 drug to Rs 899 per vial

Zydus Cadila gets USFDA final nod for low blood pressure drug Droxidopa
More Covid-19 vaccine candidates get approval for clinical trials in India
More Covid-19 vaccine candidates get approval for clinical trials in India
Zydus Cadila's Q3 net up 41% to Rs 527 cr on strong India biz growth
Zydus Cadila says 'positive results' from phase 2 studies of Covid-19 drug